Latanoprostene Bunod Reduces Intraocular Pressure in Primary Open-Angle Glaucoma Patients with Inadequate Prostaglandin Analog Response
Authors:
- Carolina N. SusannaCSCarolina N. Susanna
- Fernanda N. SusannaFSFernanda N. Susanna
- Renato GermanoRGRenato Germano
- Remo SusannaRSRemo Susanna
Open Access
- 4 November 2026
- journal article
- Published by Elsevier in Advances in Ophthalmology Practice and Research
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Visual Field Change and 24-Hour IOP-Related Profile with a Contact Lens Sensor in Treated Glaucoma PatientsOphthalmology, 2016
- Intraocular Pressure Control and Long-term Visual Field Loss in the Collaborative Initial Glaucoma Treatment StudyOphthalmology, 2011
- Canadian Glaucoma StudyArchives of Ophthalmology (1950), 2010
- Risk Factors for Visual Field Progression in Treated GlaucomaArchives of Ophthalmology (1950), 2010
- Clinical Utility of Intraocular Pressure Monitoring Outside of Normal Office Hours in Patients With GlaucomaArchives of Ophthalmology (1950), 2006
- Primary open-angle glaucomaThe Lancet, 2004
- Reduction of Intraocular Pressure and Glaucoma ProgressionArchives of Ophthalmology (1950), 2002
- The Ocular Hypertension Treatment StudyArchives of Ophthalmology (1950), 2002
- Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucomaEye, 2001
- Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressuresAmerican Journal of Ophthalmology, 1998